This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
A practical comparison of retirement index funds and target date funds, outlining when each may be the smarter pick for different retirement goals.
26,044 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Ford stock keeps going as investors bet on EV momentum and steady cash flow. This guide breaks down the factors fueli...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
As Kolibri wraps its Q4 2025 results, investors seek clarity on growth, margins, and cash flow. This article translat...
A sharp bond selloff has investors seeking guidance on where invest bonds right. This report outlines a practical app...
Scorpio Tankers has moved from a debt-laden balance sheet to net cash of roughly $334 million by early 2026, a develo...
Onity Group confirms PHH Mortgage will be renamed Onity Mortgage on March 23, part of a broader brand overhaul tied t...
Grab stock has faced a meaningful pullback, prompting many investors to ask whether a dip presents a buying opportuni...
Live events are back, but investors want proof StubHub can grow profits. This guide breaks down the stubhub (stub) 20...
A bold AI experiment in Argentina aimed at reshaping public policy stumbled on human error and bad data. The fallout ...
The Real Brokerage has added the NŌVEM Real Estate team, broadening its NYC presence across major boroughs and surrou...
SpaceX is expanding beyond rockets with a bold $60B Cursor deal. This strategic shift could redefine how investors va...